Form 8-K - Current report:
SEC Accession No. 0001157523-20-001326
Filing Date
2020-10-20
Accepted
2020-10-20 16:17:33
Documents
15
Period of Report
2020-10-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52310544.htm   iXBRL 8-K 29715
2 EXHIBIT 99.1 a52310544ex99_1.htm EX-99.1 194900
3 EXHIBIT 99.2 a52310544ex99_2.htm EX-99.2 58700
7 logo.jpg GRAPHIC 11833
  Complete submission text file 0001157523-20-001326.txt   463462

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA usna-20201020.xsd EX-101.SCH 4186
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20201020_lab.xml EX-101.LAB 23692
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20201020_pre.xml EX-101.PRE 16824
8 EXTRACTED XBRL INSTANCE DOCUMENT a52310544_htm.xml XML 4086
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 201248500
SIC: 2833 Medicinal Chemicals & Botanical Products